DXPEMEDIUM SIGNALFINANCIAL10-K

DXPE demonstrated solid operational growth with meaningful increases in revenue, operating income, and net income, while substantially expanding its debt financing and capital investments.

The company appears to be in an expansion phase, evidenced by the significant increase in capital expenditures and debt levels to fund growth initiatives. The strong operational performance with growing profitability suggests the expansion strategy is generating positive returns, though investors should monitor the increased financial leverage and debt service costs going forward.

Comparing 2026-02-26 vs 2025-03-10View on EDGAR →
FINANCIAL ANALYSIS

DXPE's financial profile shows robust operational performance with operating income growing 21.7% to $176.9M and net income increasing 25.8% to $88.7M, while total revenue expanded from $1.8 billion to $2.0 billion. The company substantially increased its debt financing by 36.4% to $330M and meaningfully expanded capital expenditures, suggesting an active growth investment cycle. Interest expense grew substantially due to the increased debt load, though strong operational cash generation appears to be supporting the expanded financial structure while total assets grew 24.9% to $1.7B.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
+82.4%
$29.1M$53.1M

Interest expense surged 82.4% — significant debt increase or rising rates materially impacting earnings.

Capital Expenditure
Cash Flow
+60.7%
$25.1M$40.3M

Capital expenditure jumped 60.7% — major investment cycle underway; assess returns on deployment.

Share Buybacks
Cash Flow
-41%
$29.0M$17.1M

Buyback activity reduced 41% — capital being redeployed elsewhere or cash conservation underway.

Current Assets
Balance Sheet
+37.5%
$661.9M$910.3M

Current assets grew 37.5% — improving short-term liquidity or inventory/receivables build.

Total Debt
Balance Sheet
+36.4%
$242.0M$330.0M

Debt increased 36.4% — substantial leverage increase; assess whether deployed for growth or covering losses.

Total Liabilities
Balance Sheet
+28.1%
$926.7M$1.2B

Liabilities increased 28.1% — monitor debt-to-equity ratio and interest coverage.

Net Income
P&L
+25.8%
$70.5M$88.7M

Net income grew 25.8% — bottom-line growth signals improving overall business health.

Total Assets
Balance Sheet
+24.9%
$1.3B$1.7B

Asset base grew 24.9% — expansion through organic growth, acquisitions, or capital deployment.

Operating Income
P&L
+21.7%
$145.4M$176.9M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

Stockholders Equity
Balance Sheet
+17.9%
$422.8M$498.4M

Equity base grew 17.9% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-03-10
ADDED
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 84 9A.
Sales, income from operations, total assets, and other financial information for our business segments are presented in Note 20 Segment Reporting to the Consolidated Financial Statements in Item 8.
Summary Sales and Income from Operations by Business Segment ______________________________________________________________________________________________________ ______________________________________________________________________________________________________ Our total sales have increased from $125 million in 1996 to $2.0 billion in 2025 through a combination of internal growth and business acquisitions.
SC sales/facility $ 8.2 $ 7.7 $ 7.5 $ 6.5 $ 5.4 $ 4.2 $ 5.3 $ 4.8 $ 3.9 $ 3.7 IPS sales $ 390 $ 309 $ 204 $ 199 $ 140 $ 188 $ 304 $ 292 $ 204 $ 187 IPS facilities 36 32 22 20 18 10 10 11 11 11 Avg.
IPS sales/facility $ 10.8 $ 9.7 $ 9.3 $ 9.9 $ 7.8 $ 18.8 $ 30.4 $ 26.5 $ 18.5 $ 17.0 SCS sales $ 253 $ 256 $ 260 $ 240 $ 158 $ 155 $ 201 $ 174 $ 161 $ 154 SCS customer sites 89 86 81 95 82 79 89 83 67 67 Avg.
+7 more — sign up free →
REMOVED
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 78 9A.
Sales, operating income, and other financial information for 2024, 2023 and 2022, and identifiable assets at the close of such years for our business segments are presented in Note 20 Segment Reporting to the Consolidated Financial Statements in Item 8.
Summary Sales and Operating Income by Business Segment ______________________________________________________________________________________________________ ______________________________________________________________________________________________________ Our total sales have increased from $125 million in 1996 to $1.8 billion in 2024 through a combination of internal growth and business acquisitions.
SC sales/facility $ 7.6 $ 7.5 $ 6.5 $ 5.4 $ 4.2 $ 5.3 $ 4.8 $ 3.9 $ 3.7 $ 4.6 IPS sales $ 323 $ 219 $ 199 $ 140 $ 188 $ 304 $ 292 $ 204 $ 187 $ 255 IPS facilities 32 22 20 18 10 10 11 11 11 12 Avg.
IPS sales/facility $ 10.1 $ 10.0 $ 9.9 $ 7.8 $ 18.8 $ 30.4 $ 26.5 $ 18.5 $ 17.0 $ 21.3 SCS sales $ 256 $ 260 $ 240 $ 158 $ 155 $ 201 $ 174 $ 161 $ 154 $ 166 SCS customer sites 86 81 95 82 79 89 83 67 67 69 Avg.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →